Beta Drugs Limited

Healthcare

NSE: BETA
₹2053.00
▼ -11.90 (-0.58%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
64/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
7.25%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
-1.6
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
₹-13 Cr
as of March 31, 2026
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 2 met
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Value and momentum

0 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-0.6%
Low 2026.6000 · High 2095.0000
1W return
-6.2%
Low 2010.5000 · High 2197.9000
1M return
-9.2%
Low 2002.6000 · High 2285.0000
52W return
13.1%
Low 990.1000 · High 2807.9000
Lifetime High ₹2668.3000 (Aug. 11, 2026)
Lifetime Low ₹39.0000 (April 1, 2020)

Full price history and technicals →

EMA & SMA

Bullish2
Bearish4
5D
2070.0
10D
2086.3
20D
2123.5
50D
2150.9
100D
2029.7
200D
1692.3

Delivery and volume

Day avg. delivery
63.2%
Week avg. delivery
54.2%
Month avg. delivery
52.3%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

2058.20
Pivot
First resistance2089.80
Second resistance2126.60
Third resistance2158.20
First support2021.40
Second support1989.80
Third support1953.00
Day RSI42.2
Day MFI55.1
Day MACD-49.18
Day MACD signal-50.00

Beta

1M1.71
3M1.81
1Y1.04
3Y1.00

Price change analysis

↓ -9.2%
Over 1 Month
LowHigh
2002.602285.00
↓ -6.0%
Over 3 Months
LowHigh
1980.002807.90
↑ 61.6%
Over 6 Months
LowHigh
1171.102807.90
↑ 13.1%
Over 1 Year
LowHigh
990.102807.90
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹56 Cr
Net profit (June 30, 2026)
₹6 Cr
Basic EPS (June 30, 2026)
₹

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter59.10%
  • FII/FPI1.02%
  • Other DII6.23%
  • Public33.65%

Largest holders

NameCategoryShares %Shares
Neeraj BatraPromoter58.4000%6473631
Suryavanshi Commotrade Private LimitedPublic6.1300%680026
Ashish KacholiaPublic4.9100%543800
Healthquad Trust IIPublic4.0900%453696
Inti Capital Vcc - Inti Capital IPublic1.9100%211691

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 59.10% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 2.95% to 1.02% in Jun 2026 qtr

Historical mutual fund holding

All shareholding details →

Insider trading, SAST & pledges

All 20 insider trades, 17 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
13 Nov 2025 Neeraj Batra Promoter Sell 0 ₹0
31 Mar 2025 Aditi Batra Promoter Buy 0 ₹0
31 Mar 2025 Heena Batra Promoter Buy 0 ₹0
31 Mar 2025 Varun Batra Promoter Buy 0 ₹0
31 Mar 2025 Rahul Batra Promoter Buy 0 ₹0
31 Mar 2025 Neeraj Batra Promoter Buy 0 ₹0
23 Jan 2023 Rahul Batra Promoter Buy 0 ₹0
20 Jan 2023 Rahul Batra Promoter Buy 0 ₹0
8 Nov 2021 Rahul Batra Promoter Buy 0 ₹0
17 Nov 2020 Vijay Kumar Batra Promoter Buy 0 ₹0

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
13 Nov 2025 NEERAJ BATRA Bulk Sell 185,115 1686.0000 NSE
13 Nov 2025 AIRAVAT CAPITAL TRUST II Bulk Buy 155,925 1686.0000 NSE
1 Sep 2020 BATRA VIJAY KUMAR Bulk Buy 50,400 84.9500 NSE
24 Jul 2020 ONKAR SINGH Bulk Buy 87,200 96.0300 NSE
24 Jul 2020 ADESH VENTURES LLP Bulk Sell 108,000 95.5200 NSE
29 Nov 2018 BATRA VIJAY KUMAR Bulk Buy 48,800 73.2500 NSE
29 Oct 2018 VALUEWORTH CAPITAL MANAGEMENT PVT LTD Bulk Sell 52,000 70.0600 NSE
29 Oct 2018 SACHIN KASERA Bulk Buy 50,400 70.0000 NSE
23 Jul 2018 VORA FINANCIAL SERVICES PRIVATELIMITED Bulk Sell 51,200 90.1400 NSE
23 Jul 2018 VORA FINANCIAL SERVICES PRIVATELIMITED Bulk Sell 51,200 90.1400 NSE

All bulk and block deals →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
3 Sep 2026 Other business matters —
20 Jul 2026 Financial Results Yes
14 May 2026 Financial Results Yes
14 Feb 2026 Financial Results Yes
9 Jan 2026 Other business matters —

Corporate Announcements

All 417 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 Shareholders meeting Beta Drugs Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
30 Sep 2026 Trading Window Beta Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
30 Sep 2026 Shareholders meeting Beta Drugs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026
22 Sep 2026 General Updates Beta Drugs Limited has informed the Exchange about Azerbaijan Oncology Market Regulatory & Commercialisation update
10 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates Beta Drugs Limited has informed the Exchange about Schedule of meet
7 Sep 2026 Copy of Newspaper Publication Beta Drugs Limited has informed the Exchange about Copy of Newspaper Publication
5 Sep 2026 Shareholders meeting Beta Drugs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
3 Sep 2026 General Updates Beta Drugs Limited has informed the Exchange about 'Beta Drugs Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 24-Sep-2026 to 30-Sep-2026 for the purpose of ANNUAL GENERAL MEETING to be held on 30.09.2026
3 Sep 2026 Shareholders meeting Beta Drugs Limited has informed the Exchange regarding Notice of undefined to be held on September 30, 2026
3 Sep 2026 Outcome of Board Meeting Beta Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Beta Drugs Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.